Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Viela Bio

Viela Bio?uq=K9LEA9hy
2017 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$282M LATEST DEAL AMOUNT
5 INVESTORS
Description

Operator of a clinical-stage biotechnology firm intended to offer treatments for severe inflammation and autoimmune diseases. The company's clinical-stage biotechnology firm offers treatment for a portfolio of critical pathways that are the root cause of disease, providing patients with deep therapeutic treatment and operational effectiveness.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • One MedImmune Way
  • First Floor, Area Two
  • Gaithersburg, MD 20878
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Viela Bio’s full profile, request a free trial.

Viela Bio Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 13-Mar-2018 $282M 00000 00000 Completed Clinical Trials - Phase 1
To view this company’s complete deal history including valuation and funding, request access »

Viela Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A3 0,000,000 00.000000 000 000 00 000 00
Series A2 00,000,000 00.000000 000 000 00 000 00.000
Series A1 14,225,324 $0.001000 $10 $10 1x $10 44.84%
To view this company’s complete Cap Table, request access »

Viela Bio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
6 Dimensions Capital Venture Capital Minority 000 0000 000000 0
Boyu Capital Advisory Company PE/Buyout Minority 000 0000 000000 0
Hillhouse Capital Group Venture Capital Minority 000 0000 000000 0
Sirona Capital PE/Buyout Minority 000 0000 000000 0
Temasek Holdings Sovereign Wealth Fund Minority 000 0000 000000 0

Viela Bio Executive Team (7)

Name Title Board
Seat
Contact
Info
Zhengbin Yao Ph.D Chief Executive Officer & Board Member
Matt Pietras Senior Director, Controller and Treasurer
Mitchell Chan Operations Executive
Soraya Madani Ph.D Vice President & Head of Portfolio Management and Regulatory Affairs
Jorn Drappa Ph.D Chief Medical Officer & Head of Research & Development
You’re viewing 5 of 7 executives. Get the full list »

Viela Bio Board Members (7)

Name Representing Role Since Contact
Info
Bahija Jallal Ph.D Self Chairman 000 0000
Edward Hu Ph.D 6 Dimensions Capital Board Member 000 0000
Sean Tong Boyu Capital Advisory Company Board Member 000 0000
Tyrell Rivers Ph.D Self Board Member 000 0000
Vincent Xiang Ph.D Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »